Clinical trial

A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose…

NCT00001579 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00001579
Title A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors
Official title A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Lymphoma, Neoplasms
Intervention type Drug
Interventions 5-Fluorouracil, Ethynyluracil, Leucovorin
Enrollment 50
Start date Jun 1, 1997
Completion Mar 1, 2001
First posted Dec 10, 2002
Last update posted Jul 17, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies